MGRX Overview

Mangoceuticals, Inc. is focused on developing, marketing, and selling a variety of health and wellness products via a secure telemedicine platform under the brands MangoRx and PeachesRx and is also focused on wellness solutions. It is advancing its proprietary antiviral compound MGX-0024. The Company offers pharmaceutical-based products specifically related to the treatments of erectile dysfunction (ED), hair growth, hormone replacement therapies, and weight management. It has developed and is commercially marketing a brand of ED products under the brand name Mango; a brand of hair loss products under the brand name Grow; a brand of hormone balance and therapy products under the name Mojo, and a brand of weight loss products under the brand name Slim. Prime by MangoRx is a TRT product available by prescription. The Mango ED product includes the three ingredients: Either Sildenafil (the active ingredient in Viagra) or Tadalafil (the active ingredient in Cialis), and Oxytocin.

Wall Street analysts forecast MGRX stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for MGRX is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Mangoceuticals Inc revenue for the last quarter amounts to 94.36K USD, decreased -10.34

Mangoceuticals Inc. EPS for the last quarter amounts to -0.13 USD, decreased -82.43

Mangoceuticals Inc (MGRX) has 0 emplpoyees as of April 03 2026.

Today MGRX has the market capitalization of 5.73M USD.